Henry Schein, Inc. HSIC is scheduled to release fourth-quarter 2024 results on Feb. 25, before the opening bell. Find the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Henry Schein Inc. closed 6.05% short of its 52-week high of $82.63, which the company achieved on February 27th.

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

This was the stock's fourth consecutive day of losses.

MELVILLE, N.Y., February 12, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, received the ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC) (“Henry Schein” or the “Company”), the world’s largest provider of health care solutions to office-based dental and ...

(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...

Henry Schein, Inc., has announced that Stanley M. Bergman, chairman of the board and CEO, has received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime ...